[1] 宁博,杨建华.α-干扰素对慢性乙肝患者外周血常规影响的临床观察.现代中西医结合杂志,2012,21:3003-3004.
[2] 李仁国,胡鹏.血府逐瘀汤联合干扰素治疗慢性乙型肝炎肝纤维化疗效观察.陕西中医,2013,23:442-443.
[3] 赵鸿,斯崇文,魏来,等,聚乙二醇化干扰素α-2b与干扰素α-2b治疗效e 抗原阳性慢性乙型肝炎的疗效和安全性的随机对照多中心研究. 中华肝脏病杂志,2006,14:323-326.
[4] Chan HL,Wong VW,Chim AM,et al.Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B.Aliment Pharmacol Ther,2010,32:1323-1331.
[5] Tangkijvanich P,Komolmit P,Mahachai V,et al.Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.J Clin Virol,2009,46:117-123. |
